Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Prifetrastat (PF-07248144) Plus Fulvestrant in Adults With Advanced HR+/HER2- Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitor Treatment
Not yet recruiting
Investigated Diseases:Investigated Drugs:
Personalizing treatment for patients with HR-positive, HER2-negative metastatic breast cancer using fulvestrant, elacestrant, capivasertib, capecitabine, or a drug combination.
Not yet recruiting
Investigated Diseases:Investigated Drugs:
Study on Alpelisib and Fulvestrant for Patients with HR+, HER2- Metastatic Breast Cancer
Not yet recruiting
Investigated Diseases:Investigated Drugs:
A study of Zr89-trastuzumab PET/CT imaging and trastuzumab emtansine treatment in patients with advanced HER2-positive breast cancer
Not yet recruiting
Investigated Diseases:Investigated Drugs:
Long-term safety study of ribociclib with letrozole, tamoxifen, or goserelin acetate in patients with HR-positive, HER2-negative advanced or metastatic breast cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of BT8009 for Patients with Advanced Breast Cancer with NECTIN4 Amplification
Not recruiting
Investigated Drugs:
Study of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment
Not recruiting
Investigated Diseases:Investigated Drugs:
+10
